Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015

Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015

The difficulties in managing multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR) TB are well known. The regimens are very expensive, often toxic, and require up to 24 months to achieve an acceptable probability of success [1–3].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European respiratory journal 2017-04, Vol.49 (4), p.1602309-1602309
Hauptverfasser: Dalcolmo, Margareth, Gayoso, Regina, Sotgiu, Giovanni, D'Ambrosio, Lia, Rocha, Jorge Luiz, Borga, Liamar, Fandinho, Fatima, Braga, Jose Ueleres, Arakaki Sanchez, Denise, Dockhorn, Fernanda, Centis, Rosella, Migliori, Giovanni Battista
Format: Artikel
Sprache:eng
Schlagworte:
Drug resistance
Multidrug resistance
Multidrug resistant organisms
Mycobacterium
Tuberculosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The difficulties in managing multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR) TB are well known. The regimens are very expensive, often toxic, and require up to 24 months to achieve an acceptable probability of success [1–3].
ISSN:0903-1936
1399-3003
DOI:10.1183/13993003.02309-2016